F-star Archives -

In this episode of Health Innovators, pharmaphorum founder Paul Tunnah interviews Eliot Forster, CEO of F-Star – a clinical-stage,

Health Innovators: Eliot Forster, F-Star

https://pharmaphorum.com/views-analysis-oncology/health-innovators-eliot-forster-f-star/

News/ News/ Oncology

Merck KGaA takes second option from cancer immunotherapy pact with F-Star

Richard Staines cancer, F-star, immunotherapy, Merck KGaA, R&D 0 Comment

Germany’s Merck KGaA has taken an option on a second cancer immunotherapy drug from its development deal with Anglo-American biotech F-star Therapeutics. The companies

Merck KGaA takes second option from cancer immunotherapy pact with F-Star

https://pharmaphorum.com/news/merck-kgaa-takes-second-option-from-cancer-immunotherapy-pact-with-f-star/

News/ R&D

Merck KGaA to develop immunotherapies with F-star

Richard Staines Bristol-Myers Squibb, cancer, F-star, immunotherapy, Merck KGaA, UK biotech 0 Comment

German Merck has option to licence LAG3-PDL1 drug.

Merck KGaA to develop immunotherapies with F-star

https://pharmaphorum.com/news/merck-kgaa-develop-cancer-immunotherapies-f-star/

News/ R&D

F-star and Denali sign potential $1bn antibody deal

Richard Staines Biotech, Bristol-Myers Squibb, Denali, F-star, R&D 0 Comment

Deal focuses on CNS bispecific antibodies.

F-star and Denali sign potential $1bn antibody deal

https://pharmaphorum.com/news/f-star-star-denali-sign-potential-1bn-antibody-deal/

Articles/ Clinical/ UK & Europe/ Views and analysis

Will the UK ever produce a world-class biotech company?

Andrew McConaghie Biotech, Cambridge, F-star, Kymab, Mission Therapeutics, UK biotech 0 Comment

Kymab, F-star and Mission Therapeutics among crop of new UK biotechs.

Will the UK ever produce a world-class biotech company?

https://pharmaphorum.com/views-and-analysis/will-uk-ever-produce-world-class-biotech-company-2/

Trending

F-star

Login